Cytogenetic study of Acute myelogenous Leukemia in Erbil City-Iraqi Kurdistan Region
Article Sidebar
Main Article Content
Abstract
Acute myelogenous leukemia is a blood disorder. It is tenth most frequent cancer, and the third leading cause of cancer death through the world. Acute myeloid leukemia is clinically heterogeneous disorder characterized by multitude of chromosomal changes. The objective of the present study is to study frequency of chromosomal aberrations (CA) in peripheral blood lymphocytes of Acute myelogenous leukemia patients in Erbil City. Blood samples were collected from 50 patients and 20 controls from both sex at different age groups. Because Acute myeloid leukemia is a heterogeneous disorder; genetic factors, smoking habit, patients occupation, blood diseases, genetic diseases and various environmental factors contribute to its development. Other factors was also studied included patient gender and age. The results showed that a significant increases in the chromosomal abnormalities in the patients when compare to control group and that highest value of chromosomal aberrations was (Dicentric chromosome) which occurred in males at fourth age group (60-69), also it showed that most patients are males who are at age group(60-69)year, Also the results showed that most of patients have smoking habit especially males, and because environmental and occupational exposures to chemicals play an important role, So the most patients have mylodysplasia blood disease.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
1. Jemal A., Thomas A., Murray T., and Thun M. (2002). Cancer statistics, Cancer J Clin 52 (1): 23–47. 2. Xie Y., Davies S.M., Xiang Y., Robison L.L. and Ross J.A.(2003). Trends in leukemia incidence and survival in the United States (1973–1998). Cancer. 97: 2229–2235. 3. General directorate of health –Hawler-2012-2016. 4. Karim Zh., Khidhir K., Ahmed R., Hassan H.G. and Karim D.O. (2016). Leukemia Study in Sulaymaniyah Province, Kurdistan, Iraq, Chin Med J(Engl). 20; 129(2): 244–245. 5. Parkin D.M., Ferlay J., Raymond L. and Young J.(2000). Cancer Incidence in Five Continents. Volume VII. IARC Scientific Pub. No. 143. Lyon, France: IARC Scientific Publications 6. Pogoda J.M., Martin S.P., Nichols P.W. and Ross R.K.( 2002). Smoking and Risk of Acute Myeloid Leukemia: Results from a Los Angeles County Case-Control Study. Am. J. Epidemiol.155 (6): 546-553. 7. Kinlen L.J. and Rogot E.(1988).Leukemia and smoking habits among United States veterans. Br Med J; 297: 657–659. 8. Garfinkel L. and Boffetta P. (2003).Association between smoking and leukemia in two American Cancer Society prospective studies, Cancer, 65: 2356–2360. 9. Chelghoum Y., Danaïla C., Belhabri1 B., Charrin C., Le O., Fiere1D. and Thomas S.(2002). Influence of cigarette smoking on the presentation and course of acute myeloid leukemia, Ann Oncol. 13 (10): 1621-1627. 10. Sanz GF., Sanz MA., Vallespí T., Cañizo MC., Torrabadella M., García S., Irriguible D.and San Miguel JF. (1989). Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood. 74 (1): 395–408. 11. Austin H., Delzell E. and Cole, P. (1988). Benzene and leukemia. A review of the literature and a risk assessment, Am J Epidemiol 127 (3): 419–39. 12. Taylor G.M. and Birch J.M. (2006). The hereditary basis of human leukemia, Leukemia (6th ed. p. 210. 13. Horrwitz M., Goode E.L. and Jarvik G.P. (1996). Anticipation in familial leukemia, Am. J. Hum. Genet. 59(5):990-8. 14. Haj F.B., Markoya L.D., Klaman F.D., Bohmer D. and Neel D.J.( 2003). Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase, J.BIOL. Chem. 278:739-744. 15. Heaney M.L and Soriano G. (2013).Acute myeloid leukemia following a myeloproliferative neoplasm: clinical characteristics, genetic features and effects of therapy, Curr Hematol Malig Rep.8(2):116-22. 16. Mrozek K. and Bloomfied C.D. (2006). Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia, Hematology Am Soc Hematol Educ Program.:169-77. 17. Yaseen N.Y. ,Humadi A.A. ,Tawfiq M.S. and Estivan A.G. (1998).Cytogenetic studies on patients with chronic Myelocytic leukemia, Med. J. Tikrit Univ.,4:5-9. 18. Drak M.T and Karpuzoglu E.(2012). Gender differences in cancer susceptibility: an inadequately addressed issue, Frontiers in Genetics.3(2).110-134. 19. Mohammad T.Kh., Mahmood A.H., Elew G.F. and Al-Khalidi S.J. (2009). A study of the prevalence of acute leukemia among a group of Iraqi patients, Journal of Al-Nahrain University.12 (2) ,pp.107-112. 20. Levi F., Lucchini F., Negri E. and La Vecchia ,C. (2002).Cancer mortality in the European Union, 1988–1997: the fall may approach 80,000 deaths a year, Int J Cancer. 98: 636–637. 21. Jemal A., Siegel R., Xu J. and Ward E.(2010). Cancer statistics, Cancer J Clin.60.277-300. 22. Sandler D. P. and Collman G.W.(1987). Cytogenetic and environmental factors in the etiology of the acute leukemias in adults, Am J Epidemiol .126: 1017–1032. 23. Sandler D.P., Shore, D.L. and Anderson J.(2013). Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst; 85(4). 24. Korte J.E., Hertz-Piccioto I. and Schulz M.R. (2000). The contribution of benzene to smoking induced leukemia, Environ Health Perspect. 108:333-9 . 25. Crane M.M., Strom S.S. and Halabi S. (1996). Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia, Cancer Epidemiol Biomarkers Prev. 5:639- 44 . 26. Lindquist R., Nilsson BS., Eklund G., Odont D.and Gahrton G.(1987) Increased risk of developing
acute leukemia after employment as a painter. Cancer Journal. 60( 6).P 1378–1384 27. Kasper D., Braunwald L. and Eugene. F. (2005). Harrison's Principles of Internal Medicine (16th ed.). New York: McGraw-Hill. p. 625. 28. Rosner F. and Lee S. (1972) .Down syndrome and acute leukemia: Myeloblastic or lymphoblastic: Report of forty-three cases and review of literature. Am J Med 53:203. 29. Shimamura A. and Alter B.P. (2010). Pathophysiology and management of inherited bone marrow failure syndromes, Blood Rev .24:101–122. 30. Martens J .H. and Stunnenberg H.G. (2010).The molecular signature of oncofusion proteins in acute myeloid leukemia, FEBS Lett.584:2662. 31. Byrd J.C., Mrozek K. and Dodge R.K.(2002). Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B(CALGB 8461), Blood. 100:4325-36. 32. Mrozek K., Radmacher M.D., Bloomfield C.D .and Marcucci G. (2009). Molecular signatures in acute myeloid leukemia. Curr Opin Hematol. 16:64-9. 33. Moorman A.V., Roman E., Willett E.V., Dovey G.J., Cartwright R.A. and Morgan G.J. (2001) Karyotype and age in acute myeloid leukemia. Are they linked? Cancer Genet Cytogenet. 126:155-161. 34. Schoch C., Kern W. and Krawitz P.(2001). Dependence of age-specific incidence of acute myeloid leukemia on karyotype ,Blood J.; 98:3500. 35. Sandler D.P., Shore D. and Anderson JR.(1993). Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow. J Natl Cancer Inst;85: 36. Agnes C., Fett C., Roseli V., Cristina B., Vendrame G., Andréa B., Carvalho S., Octávio R. and Marileila V. (2007). Atypical chromosome abnormalities in acute myeloid leukemia type M4, Genet. Mol. Biol. 3 (1).